The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $242.32 million. The enterprise value is $481.51 million.
| Market Cap | 242.32M |
| Enterprise Value | 481.51M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, before market open.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 123.63 million shares outstanding. The number of shares has increased by 9.10% in one year.
| Shares Outstanding | 123.63M |
| Shares Change (YoY) | +9.10% |
| Shares Change (QoQ) | +12.27% |
| Owned by Insiders (%) | 8.22% |
| Owned by Institutions (%) | 99.16% |
| Float | 63.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 40.82 |
| PS Ratio | 0.62 |
| Forward PS | 0.58 |
| PB Ratio | 3.83 |
| P/FCF Ratio | 30.97 |
| PEG Ratio | 0.95 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 61.54 |
Financial Position
The company has a current ratio of 6.57, with a Debt / Equity ratio of 10.80.
| Current Ratio | 6.57 |
| Quick Ratio | 5.26 |
| Debt / Equity | 10.80 |
| Debt / EBITDA | n/a |
| Debt / FCF | 87.40 |
| Interest Coverage | -4.98 |
Financial Efficiency
Return on equity (ROE) is -86.00% and return on invested capital (ROIC) is -17.48%.
| Return on Equity (ROE) | -86.00% |
| Return on Assets (ROA) | -8.60% |
| Return on Capital (ROIC) | -17.48% |
| Revenue Per Employee | $446,216 |
| Profits Per Employee | -$91,414 |
| Employee Count | 881 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.24 |
Taxes
In the past 12 months, SKIN has paid $1.23 million in taxes.
| Income Tax | 1.23M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.91% in the last 52 weeks. The beta is 1.00, so SKIN's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -76.91% |
| 50-Day Moving Average | 2.51 |
| 200-Day Moving Average | 3.41 |
| Relative Strength Index (RSI) | 41.77 |
| Average Volume (20 Days) | 1,849,727 |
Short Selling Information
The latest short interest is 9.87 million, so 7.99% of the outstanding shares have been sold short.
| Short Interest | 9.87M |
| Short Previous Month | 9.97M |
| Short % of Shares Out | 7.99% |
| Short % of Float | 15.47% |
| Short Ratio (days to cover) | 6.70 |
Income Statement
In the last 12 months, SKIN had revenue of $393.12 million and -$80.54 million in losses. Loss per share was -$0.71.
| Revenue | 393.12M |
| Gross Profit | 149.37M |
| Operating Income | -130.60M |
| Pretax Income | -79.31M |
| Net Income | -80.54M |
| EBITDA | -28.98M |
| EBIT | -66.05M |
| Loss Per Share | -$0.71 |
Balance Sheet
The company has $444.63 million in cash and $683.82 million in debt, giving a net cash position of -$239.19 million or -$1.93 per share.
| Cash & Cash Equivalents | 444.63M |
| Total Debt | 683.82M |
| Net Cash | -239.19M |
| Net Cash Per Share | -$1.93 |
| Equity (Book Value) | 63.30M |
| Book Value Per Share | 0.51 |
| Working Capital | 521.26M |
Cash Flow
In the last 12 months, operating cash flow was $17.91 million and capital expenditures -$10.08 million, giving a free cash flow of $7.82 million.
| Operating Cash Flow | 17.91M |
| Capital Expenditures | -10.08M |
| Free Cash Flow | 7.82M |
| FCF Per Share | $0.06 |
Margins
Gross margin is 38.00%, with operating and profit margins of -33.22% and -20.49%.
| Gross Margin | 38.00% |
| Operating Margin | -33.22% |
| Pretax Margin | -20.17% |
| Profit Margin | -20.49% |
| EBITDA Margin | -7.37% |
| EBIT Margin | -16.80% |
| FCF Margin | 1.99% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.10% |
| Shareholder Yield | -9.10% |
| Earnings Yield | -33.24% |
| FCF Yield | 3.23% |
Analyst Forecast
The average price target for SKIN is $4.29, which is 118.88% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.29 |
| Price Target Difference | 118.88% |
| Analyst Consensus | Hold |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 6.79% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of 0.34 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.34 |
| Piotroski F-Score | 5 |